Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vaxcyte Inc. Common Stock (PCVX) vs Trane Technologies plc (TT) Price & Performance

Vaxcyte Inc. Common StockTrade
Trane Technologies plcTrade

Price performance (Past 24H)

Key statistics

Vaxcyte Inc. Common Stock vs Trane Technologies plc — how do they compare? Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B), while Trane Technologies plc trades at $471.29 (market cap $105.17B). The key difference: Trane Technologies plc is far larger — about 10× Vaxcyte Inc. Common Stock's market cap, and Trane Technologies plc pays a 0.88% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals.

PCVXTT
Market Cap
$10.51B$105.17B
Volume
2,644,6941,040,183
Sector
HealthIndustrials
52-Week High
$73.82$503.46
52-Week Low
$40.32$376.43
Typical Hold Time
0 Days—
Enterprise Value
$9.14B$108.47B
Dividend Yield
—0.88%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PCVX
100% Buy0% Sell
Avg holding period · 0 Days
TT

No sentiment data available yet.

Top news

Latest headlines on both assets

About Vaxcyte Inc. Common Stock

Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.

Read more on PCVX →

About Trane Technologies plc

Trane Technologies plc is a global climate solutions company that designs, manufactures, and services heating, ventilation, and air conditioning (HVAC) and transport refrigeration equipment under its Trane and Thermo King brands.

Read more on TT →